The CMS has started to answer the many questions surrounding how physicians will get paid under the Medicare Access and CHIP Reauthorization Act. But some stakeholders were immediately dissatisfied with what they saw, and the 963-page rule may have raised as many questions as it answered.
Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year. Total revenue increased 21% to...
Florida just enacted one of the strongest state laws protecting consumers against surprise medical bills. What got less attention is that on the same day, Gov. Rick Scott also signed what could turn out to be one of the nation's most robust healthcare price and quality transparency systems.
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical in a cash-stock deal that aims to strengthen the medical devicemaker's share of the market for cardiovascular care.
The Santa Clara, Calif.-based company is attempting to reorganize as sales of personal computers shrink. Intel officials said the company will make investments in products and technologies, such as the cloud, that will foster revenue growth, and drive more profitable mobile and personal computer...
Kaiser Permanente has dropped its $525 million contract with Owens & Minor for medical-surgical supply distribution, marking the second time that the supplier has reported a major contract loss in less than a year.
The outgoing CEO of embattled drugmaker Valeant Pharmaceuticals will tell lawmakers Wednesday that he was "too aggressive" and made mistakes in significantly hiking prices for several critical medicines, according to testimony provided to the Associated Press.